The SELECT trial and other cardiovascular outcome trials have indicated that Semaglutide can lower the incidence of these events in high-risk populations, offering protective cardiovascular effects beyond glucose control
Personalized hormone therapy to address fatigue, mood shifts, and metabolic slowdown
I've talked to a few people who are in the eating disorder world long-term and who really understand the fallout of what intentional weight loss, especially rapid intentional weight loss, can do to a person
[RELATED: How Much Will Your Medicare Part B Premium Rise in 2026?] TRICARE covers GLP-1 drugs, such as Ozempic, that are FDA-approved to treat Type 2 diabetes for all beneficiaries under the pharmacy program
I was absolutely exhausted
I send you and your family my sincerest apologies